RA is known to be associated with an increased risk of serious infection. Even more than 50
years ago, observational studies showed a greater than 2-fold increased risk of serious …

OBJECTIVE: Mortality rates in patients with rheumatoid arthritis (RA) have been reported to
be higher than for the general population. Fortunately, efficient therapies have reduced …

Objective To determine the relationship of disease activity to infections in patients with
rheumatoid arthritis (RA). Methods From the CORRONA database, the incidence of …

Mortality rates in patients with rheumatoid arthritis (RA) are 1.5-1.6 fold higher than in the
general population, with similar patterns over 60 years. The acute attributed causes of death …

Objectives To identify serious infection (SI) risk by aetiology and site in patients with
rheumatoid arthritis (RA) compared with those with non-inflammatory rheumatic and …

Immunotherapy has markedly improved treatment outcomes in rheumatoid arthritis (RA).
Tumor necrosis factor (TNF)‑α antagonists, such as infliximab (IFX), etanercept (ETN) …

Objective To evaluate rheumatoid arthritis (RA) and mortality risk among women followed
prospectively in the Nurses' Health Study (NHS). Methods We analyzed 119,209 women in …

Objective. To determine whether MPO contributes to oxidative stress and disease activity in
RA and whether it produces hypochlorous acid in SF. Methods. Plasma and where possible …

Conventional disease-modifying antirheumatic drugs such as methotrexate are the mainstay
of treatment for rheumatoid arthritis. More recently, biologic agents such as etanercept …

Antibody titers to P. gingivalis are increased in patients with rheumatoid arthritis and are
associated with disease-specific autoimmunity. BACKGROUND: Periodontitis (PD) has been …